Formulation: A 1 mg/ml solution in methanol

Purity: ≥99% deuterated forms (d₁-d₄)

Formulation: A 1 mg/ml solution in methanol

Purity: ≥99% deuterated forms (d₁-d₅)

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• R-(+)-WIN 55,212-2

Formulation: A 1 mg/ml solution in methanol

Purity: ≥99% deuterated forms (d₁-d₅)

Formulation: A 1 mg/ml solution in methanol

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A 1 mg/ml solution in methanol

Purity: ≥99% deuterated forms (d₁-d₅)

Formulation: A 1 mg/ml solution in methanol

Purity: ≥99% deuterated forms (d₁-d₅)

• MAM2201 N-(5-hydroxypentyl) metabolite-d₅

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• 5-fluoro UR-144
• 5-FUR-144

Formulation: A 1 mg/ml solution in methanol

Purity: ≥99% deuterated forms (d₁-d₅)

Formulation: A 10 mg/ml solution in methanol

Purity: ≥98%

Schedule: I

Formulation: A 10 mg/ml solution in acetonitrile

Purity: ≥98%

Schedule: I

• (R)-5-fluoro MDMB-PINACA

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A 10 mM solution in DMSO

• Synthetic CB Screening Library

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• MDMB-PENINACA
• MDMB-PINACA N1-pentyl-4-en isomer

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A neat solid

Purity: ≥98%

Schedule: I

• ​AMB-FUBINACA
• FUB-AMB

Formulation: A 1 mg/ml solution in methanol

Formulation: A 10 mg/ml solution in methyl acetate

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

• XLR11 N-pentanoic acid metabolite

Formulation: A crystalline solid

Purity: ≥98%

• Dexanabinol

Formulation: A 10 mg/mL solution in methanol

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A neat solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 5-fluoro MDMB-2201
• MDMB-2201